Nanotechnology‐Assisted Immunoengineering for Cancer Vaccines
Nanotechnology‐Assisted Immunoengineering for Cancer Vaccines
About this item
Full title
Author / Creator
Publisher
Singapore: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Singapore: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Recently, approaches based on nano‐immunoengineering have been developed to optimize the potency of vaccines while minimizing toxicity. To achieve desirable immune responses, vaccines should be able to traffic into lymph nodes (LN) and provide antigen and inflammatory signals for a sufficient temporal duration, to activate the desired cellular and...
Alternative Titles
Full title
Nanotechnology‐Assisted Immunoengineering for Cancer Vaccines
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_34b92c5bc0ef41d7aa22565f5741cf1e
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_34b92c5bc0ef41d7aa22565f5741cf1e
Other Identifiers
ISSN
2699-9307
E-ISSN
2699-9307
DOI
10.1002/anbr.202200080
